Press Release – CounterX Therapeutics

June 3, 2026 in Press Release

CounterX Therapeutics to Present at the 88th Annual College on Problems of Drug Dependence (CPDD) Scientific Meeting

PRESS RELEASE CounterX Therapeutics to Present at the 88th Annual College on Problems of Drug Dependence (CPDD) Scientific Meeting Company leadership to highlight advances in the developm ...

April 29, 2026 in Press Release

CounterX Therapeutics Invited to Present at Science2Startup

pjwcreative 1 Like Post Comments Off

PRESS RELEASE CounterX Therapeutics Invited to Present at Science2Startup SEATTLE, WA – (April 29, 2026) CounterX Therapeutics today announced that the company has been selected to presen ...

CounterX Therapeutics to Present at the 88th Annual College on Problems of Drug Dependence (CPDD) Scientific Meeting

CounterX Therapeutics Invited to Present at Science2Startup

Puget Sound Business Journal: CounterX Therapeutics inks licensing deal for opioid abuse treatments

CounterX Therapeutics Executes Exclusive Licensing Agreement for Portfolio of Novel Monoclonal Antibody and Vaccine Candidates Targeting Fentanyl and Opioid Overdose

CounterX Therapeutics Announces Formation of Scientific Advisory Board with Leading Experts in Substance Use Disorders

Wired: A Fentanyl Vaccine Is About to Get its First Major Test

CounterX Therapeutics to Present at the 88th Annual College on Problems of Drug Dependence (CPDD) Scientific Meeting

CounterX Therapeutics Invited to Present at Science2Startup